Table 5.
Variable | β | p | Total R2 | R2 Δ | p |
---|---|---|---|---|---|
Model 1: IL-6 (log10 transformation) | |||||
Step 1 | .19 | .19 | <.001 | ||
Gender | .07 | .004 | |||
Age | .007 | <.001 | |||
Body Mass Index (BMI) | .02 | <.001 | |||
Statin Use | .03 | .28 | |||
Beta-blocker Use | −.09 | .007 | |||
Step 2 | .19 | .002 | .19 | ||
Positive Relationships | −.002 | .19 | |||
Step 3 | .20 | .01 | .001 | ||
Positive Relationships x Gender | −.01 | .001 | |||
Step 4 | .20 | .000 | .55 | ||
Positive Relationships2 | .000 | .55 | |||
Step 5 | .20 | .000 | .69 | ||
Positive Relationships2 x Gender | .000 | .69 | |||
Model 2: IL-6 (log10 transformation) | |||||
Step 1 | .19 | .19 | <.001 | ||
Gender | .07 | .004 | |||
Age | .007 | <.001 | |||
Body Mass Index (BMI) | .02 | <.001 | |||
Statin Use | .03 | .28 | |||
Beta-blocker Use | −.09 | .007 | |||
Step 2 | .19 | .002 | .26 | ||
Autonomy | −.002 | .26 | |||
Step 3 | .19 | .000 | .80 | ||
Autonomy x Gender | .001 | .80 | |||
Step 4 | .19 | .001 | .45 | ||
Autonomy2 | .000 | .45 | |||
Step 5 | .19 | .001 | .47 | ||
Autonomy2 x Gender | .000 | .47 |
Note.
p < .05. For R2 values, an asterisk indicates that the F value for the ANOVA of the full model at that step is significant. For ΔR2, an asterisk indicates that the inclusion of that step’s novel predictor produced an F value than was significantly greater than that of the previous model.